Diabetes
From the Journals
Monoclonal antibody drops fat, ups muscle in obesity, diabetes
‘Blockade of the activin receptor with bimagrumab could provide a novel pharmacologic approach for managing patients with type 2 diabetes with...
Feature
Widespread liver disease missed in patients with T2D
New evidence showing how common fatty liver disease and fibrosis are in patients with type 2 diabetes triggers a broadened “call to action.”
Photo Rounds
Generalized pruritic blisters and bullous lesions
In a patient with no history of skin disease, a recent change provided a clue to his condition.
PURLs
Can viscous fiber lower glycemic markers in type 2 diabetes?
The first meta-analysis to focus on viscous dietary fiber in T2D suggests a potential role for this supplement in improving glycemic control.
Applied Evidence
Tactics to prevent or slow progression of CKD in patients with diabetes
Annual screening of urinary parameters, ongoing clinical vigilance, and proper medical therapy can help to keep declining renal function at bay....
From the Journals
Low-carb diets boost diabetes remission rates, at least short term
From the Journals
Further warning on SGLT2 inhibitor use and DKA risk in COVID-19
Five new cases of euglycemic diabetic ketoacidosis seen in T2D patients with acute COVID-19 illness.
From the Journals
Biomarker HF risk score envisioned as SGLT2 inhibitor lodestar in diabetes
Together, four “easily measured” biomarkers predicted 5-year heart failure risk in patients with diabetes or prediabetes, potentially identifying...
Feature
Pressure builds on CDC to prioritize both diabetes types for vaccine
Feature
To fast or not? The new dieting dilemma
A number of small studies have shown that adopting some kind of “fast” as part of a diet can more easily help people lose weight, but a recent...
Feature
Endocrine Society calls for action to reduce insulin costs
New position statement is issued in year of 100th anniversary of the discovery of insulin, and as a new U.S. presidential administration is set to...